Young people’s messages to health professionals about clinical trials

The majority of young people we talked to were pleased to have taken part in a clinical trial and other types of medical research. They said it was good that clinical trials involve young people and not just adults. For many of the young people we spoke to, taking part in a clinical trial helped them to understand their condition, as well as advancing knowledge, and helping others in the future.

Both Joe, 15, and Danny, 13, were recently diagnosed with diabetes. It came as a shock to them and their families. Both took part in a randomised trial on interventions/approaches to support the self-management of diabetes for young people. Taking part has helped them better understand diabetes and how it affects them.

They are both very keen that research continues to involve young people. Danny would like to take part in similar trials to help other young people who may be diagnosed with diabetes in the future.

Clinical trials in young people should continue says Danny.

Age at interview 13

Gender Male

Age at diagnosis 4

View profile

Joe feels it is reassuring to know that people are interested to research diabetes because it…

Age at interview 15

Gender Male

Age at diagnosis 15

View profile

Young people we talked to said they were pleased with the care and support received from the research teams, doctors, and nurses when they were in trials. The majority felt that everything about the trials including what it involved and any possible side effects, was explained to them, and there was always the option of coming out of the trial.

Knowing that they could withdraw from a trial was very reassuring for young people. It was reassuring for young people and their parents to feel that their health always came first. (See also ‘Being invited to take part in a clinical trial: information and questions‘.)

Some young people we talked to suggested ways to improve the experience of taking part in a trial. Suggestions included how information is presented to young people, making medicines easier to take, talking to young people at their level and being open and honest about side effects. Young people also wanted to know the results of trials, and that their contribution was valued by the research teams. (See also ‘Getting feedback and when the trial ends’.)

Stephanie feels that health professionals need to be clear about all known side effects and not…

Age at interview 18

Gender Female

Age at diagnosis 15

View profile

Suggestions to improve information included information that is easy to read using simple explanations. Ryan, aged 12, has polyarthritis and is taking part in a randomised placebo-controlled drug trial. He says that the information he received was too difficult for him to understand because it used too many ‘long words’. At the time he was too shy to ask questions because he didn’t know any of the doctors or nurses. He feels that the doctors and research teams should introduce themselves to young people first and explain what is involved in a trial more simply.

Ryan feels that trial information can be overwhelming and difficult to understand. Using bullet…

Age at interview 12

Gender Male

Age at diagnosis 8

View profile

Ryan took the information home, and his mum helped him to understand what the trial was about and how it may help him and other children with polyarthritis in the future. Having information that is more at the child’s level might be better, including how procedures are explained.

Mohini, 12, declined to take part in a trial on treatment for cancer. (See also ‘Deciding not to take part although eligible to take part in a clinical trial‘.) She feels that the doctors, nurses, and researchers need to communicate with young people and not just their parents.

Doctors and nurses need to talk to young people says Mohini and not just their parents. A close…

Age at interview 12

Gender Female

Age at diagnosis 9

View profile

She also says that a key message researchers need to get across to young people is ‘safety’. Ensuring young people know that all drugs have been tested before being trialled is very important. If everything was known about the effects – wanted and unwanted – of treatments, there would be no need for research. Treatment, whether given as part of a trial or not, always involves some uncertainties about its effects and this should be made clear to patients and prospective participants in trials designed to reduce the uncertainties.

Mohini says that taking part in a trial that involves intensive treatment is a real commitment to…

Age at interview 12

Gender Female

Age at diagnosis 9

View profile

Hannah, 17, has had diabetes for 13 years and recently took part in a randomised trial to compare different approaches to the self-management of diabetes, such as diet. She was randomised to receive the usual way of informing young people about diabetes at her regular clinic appointments and is unaware of what the new way of informing people involved. However, she says it would be good to have group sessions or short courses on diabetes and to share experiences with other young people, from those newly diagnosed to those who have had diabetes for a long time.

Hannah would like to have had more opportunities during the trial for group sessions with…

Age at interview 17

Gender Female

Age at diagnosis 4

View profile

Hannah also suggested alternative ways of giving diabetic information to young people: “Like maybe going out on activities and showing them, like, maybe a trip to a science lab or something, like, showing you what happens. Just something a bit more interesting than reading it on paper. Sometimes you need paperwork to be able to understand it, but I, some, I just feel like some younger people might not want, be interested in reading anything. Like both my younger cousins have got it and they probably don’t know what they’ve got or like, how anything affects them.”

Sophie, 12, was diagnosed with Type 1 diabetes at the age of 3. She recently took part in a randomised trial to assess the value of an intervention for use by diabetes clinicians to help young people self-manage their condition. There was a mix of about 10 boys and girls attending the intervention, which lasted a whole day. She remembers there was also a mix of conditions including diabetes, epilepsy, and attention-deficit and hyperactivity disorder (ADHD). She says she really enjoyed the day and would like to attend similar days again in the future.

Sophie feels that keeping children and young people engaged throughout the day is important when…

Age at interview 12

Gender Female

Age at diagnosis 3

View profile

Sometimes taking medicines can be complicated, especially when there are lots of tablets involved that must be taken at different times. (See also ‘What is involved in a trial’ appointments and monitoring‘ and ‘What is involved in a trial: time commitment, costs and payment‘.)

Joanna, 17, is taking part in a randomised placebo-controlled drug trial for vasculitis. Along with extra tablets Joanna has to take a calcium drink that does not taste very nice.

Joanna thinks that making medicines easier to take for young people may help improve their…

Age at interview 17

Gender Female

Age at diagnosis 16

View profile

When there is a lot of medication to take and records to keep, having step-by-step instructions…

Age at interview 23

Gender Female

View profile

Some young people we talked to would like the tests they have as part of the trial to be quicker. For example, both Jenna and Alexander are taking part in a randomised placebo-controlled drug trial on improving treatment for arthritis. They both have certain tests done at their clinic appointments from which the information is sent to the trial organisers in another country. The pharmacy then waits for a response to ensure the correct dose of medicine is made up for them to take. Although Jenna says the system has improved it was a very slow process at the start of the trial.

Waiting for test results and medicines can be a lengthy process. Having good systems in place…

Age at interview 13

Gender Female

Age at diagnosis 11

View profile

During the trial Alexander was preparing for his A levels. In addition to speeding up the process for test results and medicines to be made up he says it would be a good idea to have a quiet area for young people to do their schoolwork.

Having a quiet area for young people to study Alexander feels would be really helpful when they…

Age at interview 18

Gender Male

Age at diagnosis 16

View profile

For other young people we interviewed, there seemed to be a lack of information about clinical trials in young people. They wanted to take part in a clinical trial and medical research but didn’t know how to get involved. They also wanted more accessible information about trials that have taken place and how it may influence future treatments.

Sophie, 22, recently took part in a research study about blood sugar levels in people with cystic fibrosis. This was her first experience of being in a trial. She says there needs to be a source of accessible information of what trials are currently recruiting and what the eligibility criteria are.

Young people often dont know how to get involved in a clinical trial or research, yet Sophie…

Age at interview 23

Gender Female

View profile

Young people we interviewed suggested ways that health professionals and researchers could engage young people to take part in trials. Some young people said they would like to talk to other young people who have been in a trial (sharing experiences like youthhealthtalk.org), and others suggested using the resources of charities and having a specific web link for trial and research information.

Using the resources of charities may help to inform young people about clinical trials. Sophie…

Age at interview 23

Gender Female

View profile

Health professionals should try harder says Robert to get young people excited about the aims of…

Gender Male

View profile

Some young people we interviewed said they felt quite alone being part of a trial. They didn’t know anyone of their age who had taken part in a trial, and rarely met other young people who were in the same trial. Sharing their experience of being in a trial with other young people was something young people would appreciate.

Robert has cystic fibrosis and is advised not to mix with other young people with cystic fibrosis because of the risk of infection. So, taking part in a trial for people with cystic fibrosis can be quite a lonely experience. He says that having a website where young people can share experiences of being in a trial might be quite fun.

Taking part in a trial can be a lonely experience, but Robert feels that sharing experiences of…

Gender Male

View profile

Ryan, 12, has polyarthritis and would like to meet other young people of his age who are taking part in a trial and having similar treatments. He says he could help to reassure other young people who may be deciding whether to take part that it is ‘okay’.

Sharing experiences of being in a trial Ryan feels may help to reassure other young people who…

Age at interview 12

Gender Male

Age at diagnosis 8

View profile

Kerenza says it would be nice to know other young people with the same condition and having…

Age at interview 15

Gender Female

Age at diagnosis 7

View profile

However, some young people may prefer not to meet with other young people but just read or see other people’s experiences via a website such as this one, for example. They also wanted to know that their contribution was valued by doctors and research teams and would like to know the progress of the trial.

Alexander would like to know if being in a trial has helped other young people with arthritis.

Age at interview 18

Gender Male

Age at diagnosis 16

View profile

Young people would like to know that the information they have given to health professionals is…

Age at interview 13

Gender Male

View profile

Many of the suggestions young people made for improving clinical trials applied to other forms of medical research too. Georgia aged 10, has been taking part in a research study on children with arthritis since she was 6. She says she would like more information about what is happening and more information about her arthritis. She would also like the researchers to ask more questions about how arthritis affects young people.

Georgina feels that younger children would like to have information at their level and more…

Age at interview 10

Gender Female

View profile

It is important health professionals understand what it is like to have arthritis as a young…

Age at interview 10

Gender Female

View profile